Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D Vaccination (CYF-8)
Sponsor: University of Aarhus
A PHASE4 clinical study on Cytotoxicity and Healthy, this trial is ongoing. The trial is conducted by University of Aarhus and has accumulated 13 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Apr 2025 — Present [monthly]
Active Not Recruiting PHASE4
-
Jan 2025 — Apr 2025 [monthly]
Active Not Recruiting PHASE4
Status: Enrolling By Invitation → Active Not Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Enrolling By Invitation PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation PHASE4
-
May 2024 — Jul 2024 [monthly]
Enrolling By Invitation PHASE4
▶ Show 8 earlier versions
-
Jun 2023 — May 2024 [monthly]
Enrolling By Invitation PHASE4
Status: Unknown Status → Enrolling By Invitation
-
Dec 2022 — Jun 2023 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
-
Nov 2021 — Dec 2022 [monthly]
Active Not Recruiting PHASE4
-
Apr 2021 — Nov 2021 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Recruiting PHASE4
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Apr 2020 — Dec 2020 [monthly]
Recruiting PHASE4
-
Oct 2019 — Apr 2020 [monthly]
Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Aarhus
For direct contact, visit the study record on ClinicalTrials.gov .